Bank of New York Mellon’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History

Bank of New York Mellon’s Portfolio CBIO Stock Details CBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-247	Closed	-$58.4K	–	4213
2023 Q4	$58.4K	Sell	247 -2	-0.8%	-$473	﹤0.01%	4139
2023 Q3	$37.3K	Sell	249 -2	-0.8%	-$300	﹤0.01%	4180
2023 Q2	$43.7K	Sell	251 -1	-0.4%	-$174	﹤0.01%	4187
2023 Q1	$31.7K	Sell	252 -10	-4%	-$1.26K	﹤0.01%	4254
2022 Q4	$79.3K	Hold	262	–	–	﹤0.01%	4162
2022 Q3	$14K	Hold	262	–	–	﹤0.01%	4479
2022 Q2	$16K	Sell	262 -1	-0.4%	-$61	﹤0.01%	4511
2022 Q1	$30K	Hold	263	–	–	﹤0.01%	4586
2021 Q4	$38K	Hold	263	–	–	﹤0.01%	4535
2021 Q3	$58K	Sell	263 -4	-1%	-$882	﹤0.01%	4403
2021 Q2	$62K	Sell	267 -1,096	-80%	-$255K	﹤0.01%	4289
2021 Q1	$410K	Buy	1,363 +41	+3%	+$12.3K	﹤0.01%	3791
2020 Q4	$496K	Buy	1,322 +30	+2%	+$11.3K	﹤0.01%	3622
2020 Q3	$397K	Buy	1,292 +30	+2%	+$9.22K	﹤0.01%	3599
2020 Q2	$474K	Buy	1,262 +43	+4%	+$16.2K	﹤0.01%	3509
2020 Q1	$278K	Buy	1,219 +89	+8%	+$20.3K	﹤0.01%	3628
2019 Q4	$598K	Sell	1,130 -243	-18%	-$129K	﹤0.01%	3495
2019 Q3	$592K	Sell	1,373 -87	-6%	-$37.5K	﹤0.01%	3439
2019 Q2	$1.74M	Sell	1,460 -4	-0.3%	-$4.77K	﹤0.01%	2870
2019 Q1	$1.82M	Buy	1,464 +22	+2%	+$27.4K	﹤0.01%	2827
2018 Q4	$1.37M	Buy	1,442 +28	+2%	+$26.5K	﹤0.01%	2923
2018 Q3	$2.04M	Buy	1,414 +30	+2%	+$43.2K	﹤0.01%	2819
2018 Q2	$2.23M	Buy	1,384 +1,043	+306%	+$1.68M	﹤0.01%	2789
2018 Q1	$554K	Sell	341 -536	-61%	-$871K	﹤0.01%	3536
2017 Q4	$1.47M	Sell	877 -61	-7%	-$102K	﹤0.01%	3012
2017 Q3	$1.31M	Buy	938 +9	+1%	+$12.6K	﹤0.01%	3076
2017 Q2	$1.04M	Buy	929 +571	+159%	+$637K	﹤0.01%	3230
2017 Q1	$195K	Hold	358	–	–	﹤0.01%	3882
2016 Q4	$219K	Buy	358 +10	+3%	+$6.12K	﹤0.01%	3871
2016 Q3	$249K	Buy	348 +51	+17%	+$36.5K	﹤0.01%	3830
2016 Q2	$216K	Buy	+297	New	+$216K	﹤0.01%	3872
2014 Q2	–	Sell	-205	Closed	-$335K	–	4166
2014 Q1	$335K	Buy	+205	New	+$335K	﹤0.01%	3693